Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Cannabinoid receptor 2 | ||
| Ligand | BDBM50341003 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_740154 (CHEMBL1763214) | ||
| EC50 | 11600±n/a nM | ||
| Citation |  Riether, D; Wu, L; Cirillo, PF; Berry, A; Walker, ER; Ermann, M; Noya-Marino, B; Jenkins, JE; Albaugh, D; Albrecht, C; Fisher, M; Gemkow, MJ; Grbic, H; Löbbe, S; Möller, C; O'Shea, K; Sauer, A; Shih, DT; Thomson, DS 1,4-Diazepane compounds as potent and selective CB2 agonists: optimization of metabolic stability. Bioorg Med Chem Lett21:2011-6 (2011) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Cannabinoid receptor 2 | |||
| Name: | Cannabinoid receptor 2 | ||
| Synonyms: | CANNABINOID CB2 | CB-2 | CB2 | CB2A | CB2B | CNR2 | CNR2_HUMAN | CX5 | Cannabinoid CB2 receptor | Cannabinoid receptor 2 (CB2) | Cannabinoid receptor 2 (CB2R) | hCB2 | ||
| Type: | G Protein-Coupled Receptor (GPCR) | ||
| Mol. Mass.: | 39690.94 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P34972 | ||
| Residue: | 360 | ||
| Sequence: |
| ||
| BDBM50341003 | |||
| n/a | |||
| Name | BDBM50341003 | ||
| Synonyms: | CHEMBL1762422 | Trans-N-(5-tert-butylisoxazol-3-yl)-4-(4-hydroxycyclohexanecarbonyl)-1,4-diazepane-1-carboxamide | ||
| Type | Small organic molecule | ||
| Emp. Form. | C20H32N4O4 | ||
| Mol. Mass. | 392.4925 | ||
| SMILES | CC(C)(C)c1cc(NC(=O)N2CCCN(CC2)C(=O)[C@H]2CC[C@H](O)CC2)no1 |r,wU:19.19,wD:22.23,(7.53,-39.36,;6.3,-38.45,;6.48,-36.92,;7.62,-37.67,;4.89,-39.06,;3.56,-38.27,;2.4,-39.29,;.9,-38.96,;-.14,-40.09,;.32,-41.56,;-1.64,-39.76,;-1.99,-38.27,;-3.39,-37.61,;-4.8,-38.36,;-5.06,-39.83,;-4.11,-41.01,;-2.63,-41.01,;-6.55,-40.22,;-6.97,-41.7,;-7.63,-39.12,;-9.11,-39.51,;-10.19,-38.4,;-9.77,-36.92,;-10.84,-35.81,;-8.28,-36.54,;-7.21,-37.64,;3.02,-40.71,;4.55,-40.56,)| | ||
| Structure | 
| ||